Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Atherosclerosis. 2014 Oct 17;237(2):609–617. doi: 10.1016/j.atherosclerosis.2014.09.036

Table 1.

Plasma lipid concentrations (mg/dL) (Mean ± SEM)

TC FC CE TG
L1-KO 120 ± 3b 32 ± 1ab 147 ± 4b 69 ± 5a
L1IntOnly 141 ± 7a 36 ± 2a 176 ± 10a 65 ± 4a
L1IntOnly&Ezet 113 ± 9b 29 ± 2b 140 ± 12b 68 ± 12a
DKO 306 ± 15b 87 ± 6b 365 ± 20b 78 ± 4b
DKO/L1IntOnly 478 ± 5a 191 ± 15a 479 ± 33a 119 ± 15a
DKO/L1IntOnly&Ezet 319 ± 15b 83 ± 6b 395 ± 27b 99 ± 10ab

Mice were fasted for 4 h during the daytime cycle prior to collection of blood samples for analyses of plasma concentrations of total cholesterol (TC), free cholesterol (FC), and triglyceride (TG). The amount of cholesterol ester was calculated by subtracting free cholesterol from total cholesterol and multiplying by 1.67 to convert to cholesterol ester mass. For each parameter, values among single L1-KO background groups [L1-KO (n = 11), L1IntOnly (n = 8), and L1IntOnly&Ezet (n = 7)] or among DKO background groups [DKO (n = 10), DKO/L1IntOnly (n = 8), and DKO/L1IntOnly&Ezet (n = 7)] not sharing a common superscript letter are significantly different (P < 0.05). Ezet, ezetimibe